ArticlePLoS neglected tropical diseases2026
Brucella outer membrane protein 16 induces trophoblast pyroptosis via rewiring IL-6 trans-signaling and caspase-3/GSDME axis.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucellosis is a prevalent zoonotic disease that poses a serious threat to human health, particularly during pregnancy, where infection is strongly associated with spontaneous abortion. However, the mechanisms by which Brucella infection disrupts placental function remain poorly understood. Trophoblast cells are essential for placental development and represent primary targets of Brucella infection at the maternal-fetal interface. In this study, we investigated the effects of Brucella outer membrane lipoprotein 16 (L16) on trophoblast cell fate using the human JEG-3 cell line. L16 markedly suppressed trophoblast cell proliferation and induced membrane damage, as evidenced by increased lactate dehydrogenase release. Unlike lipopolysaccharide stimulation, L16 triggered a lytic, non-apoptotic form of programmed cell death characterized by plasma membrane ballooning. Mechanistically, L16 activated caspase-3 and promoted cleavage of gasdermin E (GSDME) into its pore-forming N-terminal fragment, thereby executing GSDME-dependent pyroptosis. Silencing of caspase-3 abolished GSDME cleavage and significantly attenuated pyroptotic cell death, confirming the essential role of the caspase-3/GSDME axis. Further analysis revealed that L16 reprogrammed inflammatory and survival signaling in trophoblast cells. L16 suppressed interleukin-6 (IL-6) trans-signaling by downregulating IL-6 receptor expression and up-regulating suppressor of cytokine signaling 3 (SOCS3), leading to inhibition of the JAK2/STAT3 pathway. Concurrently, L16 inhibited PI3K/AKT signaling and reduced phosphorylation of X-linked inhibitor of apoptosis protein (XIAP), thereby releasing inhibitory constraints on caspase-3 activation. Transcriptomic profiling supported coordinated repression of IL-6/JAK/STAT3 and PI3K/AKT pathways following L16 exposure. Collectively, these findings identify L16 as a key Brucella virulence factor that induces trophoblast pyroptosis by rewiring IL-6 trans-signaling and survival pathways, providing new mechanistic insight into Brucella-associated pregnancy failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.